54 346 (Lithium 450 mg)
Pill imprint 54 346 has been identified as Lithium carbonate extended release 450 mg.
Lithium is used in the treatment of bipolar disorder; borderline personality disorder; schizoaffective disorder; depression; intermittent explosive disorder (and more), and belongs to the drug class miscellaneous antipsychotic agents. There is positive evidence of human fetal risk during pregnancy. Lithium 450 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- 54 346
- Strength:
- 450 mg
- Color:
- White
- Size:
- 11.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous antipsychotic agents
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Roxane Laboratories, Inc.
- National Drug Code (NDC):
- 00054-0020
- Inactive Ingredients:
- ferrosoferric oxide
magnesium stearate
povidone
sodium alginate
sodium starch glycolate type A potato
Note: Inactive ingredients may vary.
| NDC Code | Manufacturer / Repackager |
|---|---|
| 68084-0655 | Amerisource Health Services |
More about lithium
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 241 Reviews – Add your own review/rating
- Drug class: miscellaneous antipsychotic agents
Consumer resources
- Lithium
- Lithium controlled-release and extended-release tablets
- Lithium syrup
- Lithium (Advanced Reading)
Other brands: Eskalith, Lithobid, Eskalith-CR
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
